Friday · October 9, 2026
Sign in
Archives

New Clinical Trials Explore Microbiome-Based Therapies for IBS

Several biotechnology firms are launching clinical studies focused on microbiome-based interventions for gastrointestinal disorders. The trials aim to evaluate whether targeted bacterial therapies can help regulate inflammation and…

Derrick Hayes
Archives · · 1 min read

Several biotechnology firms are launching clinical studies focused on microbiome-based interventions for gastrointestinal disorders.

The trials aim to evaluate whether targeted bacterial therapies can help regulate inflammation and improve digestive system stability in IBS patients.

Emerging Gastrointestinal Treatments

Participants are undergoing microbiome sequencing alongside symptom tracking and dietary monitoring during the study period.

Researchers say microbiome-focused therapeutics may eventually complement existing gastrointestinal treatment strategies.

Derrick Hayes
Derrick Hayes

Derrick Hayes is a health and science writer covering nutrition, performance, and healthy aging. He holds a bachelor’s degree in exercise science from the University of Texas at Austin and has written about fitness and applied health for more than a decade. His work translates research into practical guidance for everyday readers. At BiomeSci, he focuses on the applied side of microbiome science.

More from this section

Emerging

Antibiotics before or after FMT raise C. diff relapse risk

A retrospective study of 124 patients treated with fecal microbiota transplantation for C. diff infection found that taking antibiotics for an unrelated reason, either before or after the transplant, roughly tripled the odds of the infection coming back. Overall, three in four patients improved within a week, but the findings point to a concrete step, limiting non essential antibiotics around the time of FMT, that could improve those odds further.

6 min read
Emerging

ADHD, Autism, Depression Gene Risk Shifts With Age

A Molecular Psychiatry analysis of the ALSPAC UK birth cohort finds that polygenic risk scores for ADHD, autism, and depression predict different peer, school/employment, and suicidality outcomes depending on whether you look in childhood, adolescence, or young adulthood. No gut-microbiome findings are involved.

7 min read
Investigational

New Theory Ties Gut Wall Damage to MS and Brain Disease

Researchers at Mayo Clinic, Harvard Medical School, and Colorado State University propose a new framework in Annals of Neurology: the gut wall acts as both a site of immune priming in multiple sclerosis and a direct target of autoimmune attack in related neurological diseases like NMOSD and anti-DPPX encephalitis.

7 min read